Keyword: Celgene

News

Teva CEO Erez Vigodman Steps Down

08.02.2017 - Erez Vigodman and the board of Israel’s Teva Pharmaceutical Industries – the world’s largest generics drugmaker – have announced that the chief executive, who has led the company...

News

Trump Discusses Issues With Drugmakers

01.02.2017 - In a meeting at the White House on Jan. 31, new US president, Donald Trump, held out both a carrot and a stick to pharmaceutical producers. The industry will “have to “get prices...

News

Pharma Stocks Crash on Trump Pricing Hints

13.01.2017 - American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an...

News

Pfizer Takes Medivation for $14 billion

22.08.2016 - Pfizer has won the race for biotech firm Medivation. The US drugs giant has agreed to pay about $14 billion in a move that adds leading prostate cancer drug Xtandi to its portfolio...

News

Celgene and Jounce in Cancer Drug Collaboration

21.07.2016 - Celgene and Jounce Therapeutics are collaborating to develop and commercialize immuno-oncology treatments. The deal gives Celgene options on Jounce’s lead product candidate...

News

New Immunotherapy Coalition Launched in US

13.01.2016 - Five major internationally active drugmakers, including American biotech firms Amgen and Celgene, along with pharmaceutical giant Pfizer and non-US players such as Glaxo SmithKline...

Markets & Companies

Leaving the Patent Cliff Behind

07.10.2015 - The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...

News

Celgene Offers $7.2 Billion for Receptos

17.07.2015 - US biotech firm Celgene has agreed to pay $7.2 billion, or $232 per share, to acquire compatriot Receptos, a biotech company that makes a potential blockbuster drug to treat...